Molecular Pathogenesis of PVD
Learn more on how we identify new therapeutic targets.
Endothelial dysfunction is a hallmark of most vascular diseases, affecting all major organs such as the lung or the brain. Pulmonary vascular diseases (PVD) and pulmonary arterial hypertension in particular are vasoproliferative conditions characterized by severe endothelial dysfunction in the lung. Endothelial dysfunction in the brain is associated with numerous neurological disorders such as Alzheimer's disease. We apply an integrative multi-omics approach supplemented by in silico-based bioinformatics and functional cell biology to decipher the pathological molecular signatures of endothelial cells in vascular diseases and cancer. By developing organo-specific AAV vectors specifically-targeting endothelial cells we are able to study the molecular basis of endothelial dysfunction and evaluate the potential of new endothelium-based pharmacological and gene therapies.
Learn more on how we identify new therapeutic targets.
Read more about our AAV-based gene therapy approaches.
Meet our interdisciplinary team and collaborators.
Selected publications from our team members.
Latest updates from our lab.
Where to find us at the UKE Research Campus.